Clinical Trial Update: The Acute Effect of 2 Different Serving Regimens of Theobromine on Physiological Effects [NA]

View source ↗

Summary

Unilever R&D evaluated two serving regimens of theobromine and their acute physiological effects on cardiovascular-related measures; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Theobromine (Theobromine)

Snippet

Sponsor: Unilever R&D | Conditions: Cardiovascular Diseases | NA | Status: COMPLETED